Author | Cable, Jennifer | |
Author | Fauci, Anthony | |
Author | Dowling, William E. | |
Author | Günther, Stephan | |
Author | Bente, Dennis A. | |
Author | Yadav, Pragya Dhruv | |
Author | Madoff, Lawrence C. | |
Author | Wang, Lin-Fa | |
Author | Arora, Rahul K. | |
Author | Kerkhove, Maria Van | |
Author | Chu, May C. | |
Author | Jaenisch, Thomas | |
Author | Epstein, Jonathan H. | |
Author | Frost, Simon David William | |
Author | Bausch, Daniel G. | |
Author | Hensley, Lisa E. | |
Author | Bergeron, Éric | |
Author | Sitaras, Ioannis | |
Author | Gunn, Michael D. | |
Author | Geisbert, Thomas W. | |
Author | Muñoz-Fontela, César | |
Author | Krammer, Florian | |
Author | Wit, Emmie de | |
Author | Nordenfelt, Pontus | |
Author | Saphire, Erica Ollmann | |
Author | Gilbert, Sarah C. | |
Author | Corbett, Kizzmekia S. | |
Author | Branco, Luis M. | |
Author | Baize, Sylvain | |
Author | Doremalen, Neeltje van | |
Author | Krieger, Marco Aurelio | |
Author | Clemens, Sue Ann Costa | |
Author | Hesselink, Renske | |
Author | Hartman, Dan | |
Access date | 2022-12-22T19:39:13Z | |
Available date | 2022-12-22T19:39:13Z | |
Document date | 2022 | |
Citation | CABLE, Jennifer et al. Lessons from the pandemic: responding to emerging zoonotic viral diseases: a Keystone Symposia report. Annals of the New York Academy of Sciences, p. 1–17, 2022. | en_US |
ISSN | 0077-8923 | |
URI | https://www.arca.fiocruz.br/handle/icict/56185 | |
Language | eng | en_US |
Publisher | New York Academy of Sciences | en_US |
Rights | open access | |
Title | Lessons from the pandemic: responding to emerging zoonotic viral diseases—a Keystone Symposia report | en_US |
Type | Article | |
DOI | 10.1111/nyas.14898 | |
Abstract | The COVID-19 pandemic caught the world largely unprepared, including scientific and policy communities. On April 10–13, 2022, researchers across academia, industry, government, and nonprofit organizations met at the Keystone symposium “Lessons from the Pandemic: Responding to Emerging Zoonotic Viral Diseases” to discuss the successes and challenges of the COVID-19 pandemic and what lessons can be applied moving forward. Speakers focused on experiences not only from the COVID-19 pandemic but also from outbreaks of other pathogens, including the Ebola virus, Lassa virus, and Nipah virus. A general consensus was that investments made during the COVID-19 pandemic in infrastructure, collaborations, laboratory and manufacturing capacity, diagnostics, clinical trial networks, and regulatory enhancements—notably, in low-to-middle income countries—must be maintained and strengthened to enable quick, concerted responses to future threats, especially to zoonotic pathogens. | en_US |
Affilliation | PhD Science Writer. New York, New York, USA. | en_US |
Affilliation | Laboratory of Immunoregulation. National Institute of Allergy and Infectious Diseases. National Institutes of Health. Bethesda, Maryland, USA. | en_US |
Affilliation | Coalition for Epidemic Preparedness Innovations. Oslo, Norway. | en_US |
Affilliation | Bernhard Nocht Institute for Tropical Medicine and German Center for Infection Research. Hamburg, Germany. | en_US |
Affilliation | University of Texas Medical Branch. Galveston National Laboratory. Galveston, Texas, USA / Division of Biology and Biological Engineering. California Institute of Technology. Pasadena, California, USA. | en_US |
Affilliation | Indian Council of Medical Research-National Institute of Virology. Pune, India. | en_US |
Affilliation | Department of Medicine. University of Massachusetts Chan School of Medicine. Worcester, Massachusetts, USA. | en_US |
Affilliation | Duke-NUS Medical School. Singapore. | en_US |
Affilliation | Department of Community Health Sciences. University of Calgary. Calgary, Alberta, Canada / Institute of Biomedical Engineering. University of Oxford. Oxford, UK. | en_US |
Affilliation | World Health Organization. Geneva, Switzerland. | en_US |
Affilliation | Colorado School of Public Health. Anschutz Medical Campus. Aurora, Colorado, USA. | en_US |
Affilliation | Colorado School of Public Health. Anschutz Medical Campus. Aurora, Colorado, USA. | en_US |
Affilliation | Eco Health Alliance. New York, USA. | en_US |
Affilliation | Microsoft Research. Redmond. Washington, USA. | en_US |
Affilliation | FIND. The global alliance for diagnostics. Geneva, Switzerland. | en_US |
Affilliation | Partnership for Research on Vaccines and Infectious Diseases in Liberia. Monrovia, Liberia / Division of Clinical Research. National Institute of Allergy and Infectious Diseases. Bethesda, Maryland, USA. | en_US |
Affilliation | Viral Special Pathogens Branch. Division of High-Consequence Pathogens and Pathology. Centers for Disease Control and Prevention. Atlanta, Georgia, USA. | en_US |
Affilliation | W. Harry Feinstone Department of Molecular Microbiology and Immunology. Johns Hopkins Bloomberg School of Public Health. Baltimore, Maryland, USA. | en_US |
Affilliation | Department of Medicine. Duke University Medical Center. Durham, North Carolina, USA. | en_US |
Affilliation | University of Manitoba. Winnipeg, Manitoba, Canada / Galveston National Laboratory and Department of Microbiology and Immunology. University of Texas Medical Branch. Galveston, Texas, USA. | en_US |
Affilliation | Bernhard Nocht Institute for Tropical Medicine and German Center for Infection Research. Hamburg, Germany. | en_US |
Affilliation | Department of Microbiology and Department of Pathology. Icahn School of Medicine at Mount Sinai. New York, USA. | en_US |
Affilliation | Laboratory of Virology. Division of Intramural Research. National Institute of Allergy and Infectious Diseases. National Institutes of Health. Hamilton, Montana, USA. | en_US |
Affilliation | Department of Clinical Sciences Lund. Infection Medicine. Faculty of Medicine. Lund University. Lund, Sweden. | en_US |
Affilliation | Center for Infectious Disease and Vaccine Research. La Jolla Institute for Immunology. La Jolla, California, USA. | en_US |
Affilliation | Pandemic Sciences Institute. Nuffield Department of Medicine. University of Oxford. Oxford, UK. | en_US |
Affilliation | Department of Immunology and Infectious Diseases. Harvard T.H. Chan School of Public Health. Boston. Massachusetts, USA. | en_US |
Affilliation | Zalgen Labs. Germantown. Maryland, USA. | en_US |
Affilliation | Unité de Biologie des Infections Virales Emergentes. Institut Pasteur. Lyon, France / Centre International de Recherche en Infectiologie (CIRI). Lyon, France / INSERM. Ecole Normale Supérieure de Lyon. Université de Lyon. Lyon, France. | en_US |
Affilliation | Laboratory of Virology. Division of Intramural Research. National Institute of Allergy and Infectious Diseases. National Institutes of Health. Hamilton, Montana, USA. | en_US |
Affilliation | Fundação Oswaldo Cruz. Instituto Carlos Chagas. Laboratório de Ciências e Tecnologias Aplicadas em Saúde. Curitiba, PR, Brasil / Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Programa Translacional Integrado de Doença de Chagas da Fiocruz (Fio-Chagas). Rio de Janeiro, RJ, Brasil. | en_US |
Affilliation | Oxford Vaccine Group. Oxford University. Oxford, UK / Institute for Global Health. University of Siena. Siena, Italy. | en_US |
Affilliation | Coalition for Epidemic Preparedness Innovations. Oslo, Norway. | en_US |
Affilliation | Bill & Melinda Gates Foundation. Seattle. Washington, USA. | en_US |
Subject | Ebolavirus | en_US |
Subject | Communicable Diseases | en_US |
Subject | Infectious Diseases | en_US |
Subject | Lassa virus | en_US |
Subject | Nipah Virus | en_US |
Subject | Vaccines | en_US |
Subject | Zoonotic Diseases | en_US |
Subject in Spanish | Ebolavirus | en_US |
Subject in Spanish | Enfermedades Transmisibles | en_US |
Subject in Spanish | Virus Lassa | en_US |
Subject in Spanish | Virus Nipah | en_US |
Subject in Spanish | Vacunas | en_US |
Subject in Spanish | Zoonosis | en_US |
Subject in French | Maladies transmissibles | en_US |
Subject in French | Virus de Lassa | en_US |
Subject in French | Virus Nipah | en_US |
Subject in French | Vaccins | en_US |
DeCS | COVID-19 | en_US |
DeCS | Ebolavirus | en_US |
DeCS | Doenças Transmissíveis | en_US |
DeCS | Doenças Infecciosas | en_US |
DeCS | Vírus Lassa | en_US |
DeCS | Vírus Nipah | en_US |
DeCS | Vacinas | en_US |
DeCS | Zoonoses | en_US |
xmlui.metadata.dc.subject.ods | 03 Saúde e Bem-Estar | |